- Home
- IXHL vs EKSO Comparison
IXHL vs EKSO Comparison
Compare IXHL & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IXHL | EKSO |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.0M | 37.9M |
| IPO Year | 2024 | 2012 |
Fundamental Metrics
Financial Performance| Metric | IXHL | EKSO |
|---|---|---|
| Price | $3.63 | $10.26 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | ★ 459.9K | 58.4K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | $81.23 |
| Revenue Next Year | N/A | $7.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.11 | $0.23 |
| 52 Week High | $6.39 | $13.50 |
Technical Indicators
Market Signals| Indicator | IXHL | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 52.21 |
| Support Level | $0.34 | $9.18 |
| Resistance Level | $3.68 | $11.18 |
| Average True Range (ATR) | 0.34 | 0.93 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 88.72 | 64.42 |
Price Performance
Historical ComparisonAbout IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.